Gatoc, Emma S.

HRN: 03-37-19  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2022
CEFTRIAXONE 1G (VIAL)
05/06/2022
05/13/2022
PO
2gm
OD
CAP-MR
Waiting Final Action 
05/06/2022
AZITHROMYCIN 500MG TABLET (TAB)
05/06/2022
05/10/2022
PO
500
OD
CAP-MR
Waiting Final Action 
05/09/2022
MUPIROCIN 2%, 15G (TUBE)
05/09/2022
05/15/2022
TOPICAL
15gm
BID
Decubitus Ulcer Stage 1
Waiting Final Action 
05/14/2022
CEFIXIME 200MG (CAP)
05/14/2022
05/18/2022
PO
200 Mg
BID
CAP-MR
Waiting Final Action 
05/14/2022
CLARITHROMYCIN 500MG (CAP)
05/14/2022
05/20/2022
PO
500 Mg
BID
CAP-MR
Waiting Final Action 
10/31/2024
CEFTRIAXONE 1G (VIAL)
10/31/2024
11/06/2024
IV
2g
Once Daily
CAPMR
Waiting Final Action 
10/31/2024
AZITHROMYCIN 500MG TABLET (TAB)
10/31/2024
11/04/2024
PO
500mg OD
Once Daily
CAPMR
Waiting Final Action 
11/01/2024
CEFTAZIDIME 1GM (VIAL)
11/01/2024
11/08/2024
IV
2g
OD
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: